Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Health Endeavors has introduced an AI-based care management suite called Alex and secured funding from Decathlon Capital Partners to support expansion and technology advancement.
Nordic Capital has agreed to sell life sciences software provider ArisGlobal to Dassault Systèmes. The deal marks a full exit for Nordic Capital following its investment in 2019 and is expected to close in the second half of 2026, pending regulatory approval.
Agilisium has been named a Select Services Partner in Anthropic’s Claude Partner Network, expanding its work with Claude-powered AI solutions for Life Sciences clients.
Tally has announced a collaboration with Liminal to automate complex billing operations for specialty healthcare providers using its agentic AI platform. The partnership targets inefficiencies in the U.S. revenue cycle management market, valued at over $125 billion.
Moon Surgical has entered a strategic commercial collaboration with KARL STORZ to integrate the Maestro platform with KARL STORZ 3D visualization and instrumentation, aiming to expand access to advanced laparoscopic surgery.
Sentante has received CE marking for its haptic endovascular robotic platform designed for remote vascular procedures. The system captures force, torque, and motion data from each procedure, laying the groundwork for future AI-supported endovascular interventions.
Cigna Healthcare announced an AI expansion to its personalized care management programs, aiming to identify health needs sooner and connect more customers with clinical support.
SimBioSys has partnered with Ferrum Health to make its FDA-cleared TumorSight Viz platform available through Ferrum's Model Hub, improving deployment and management of AI surgical planning capabilities across U.S. health systems.
Genesis Automation Healthcare will debut its unified platform and introduce the Agentic AI Design Partner Program at AHRMM26 in San Antonio, marking its first public appearance as a combined company.
An independent American Heart Association AI Impact Report found that Ultromics' EchoGo Heart Failure system could identify heart failure with preserved ejection fraction up to nine months earlier than standard care.
EBSCO Clinical Decisions has partnered exclusively with the International Home Care Nurses Organization to integrate validated clinical competencies into its Dynamic Health platform, providing home care professionals with evidence-based guidance for safer patient care.
The Digital Medicine Society (DiMe) has introduced a new initiative, 'Operationalizing AI Governance in Healthcare', to provide practical tools and templates for responsible AI deployment in healthcare systems, developed with Qualified Health as the title sponsor.
Karoo Health has secured $16.2 million in Series A funding, co-led by 7wire Ventures and Allumia Ventures, to expand its AI cardiovascular care platform and partnerships with health plans and cardiology providers.
Bristol Myers Squibb will deploy NVIDIA's DGX Vera Rubin NVL72 systems to enhance its AI capabilities across drug discovery and development, expanding its existing collaboration with the chipmaker to create the most powerful AI infrastructure in life sciences.
Haier Biomedical presented its digital blood management platform at the ISBT Congress 2026 in Kuala Lumpur, highlighting integrated solutions for blood collection, processing, storage, and clinical application using IoT and AI technologies.
Ping An Insurance showcased new AI-powered products at the World Artificial Intelligence Conference 2026, introducing healthcare, insurance, and financial technologies to enhance efficiency and accessibility.
Fuse Oncology has launched FuseRx, a prescribing and treatment-intent platform for radiation oncology, debuting at the 2026 AAPM Annual Meeting in Vancouver. The system integrates prescribing, simulation, and treatment planning into one guided workflow with built-in validation and pathway support.
An independent study by Stanford and Harvard researchers found that physicians chose OpenEvidence more frequently than ChatGPT, Claude, Gemini, and all other external AI chatbots combined when given unrestricted access to clinical tools.
Bluestaq has introduced BLUESTAQ / ARQ, a multi-environment data infrastructure platform built for secure and compliant data management across sectors including healthcare, finance, agriculture, and government.
MANE has obtained global rights to produce and commercialize Arzeda's ViaLeaf Reb M sweetener technology, expanding their sugar reduction partnership.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
